Single-Dose Intranasal or Intramuscular Administration of Simian Adenovirus-Based H1N1 Vaccine Induces a Robust Humoral Response and Complete Protection in Mice
Viruses · 2025
DOI: 10.3390/v17081085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Daria V Voronina und 12 weiteren Autor:innen. Beteiligte Einrichtung: N. F. Gamaleya Federal Research Center for Epidemiology & Microbiology, Ministry of Health, Moscow 123098, Russia. Hauptthemen laut MEDLINE: Influenza A Virus, H1N1 Subtype, Influenza Vaccines, Orthomyxoviridae Infections, Adenoviruses, Simian. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Assignment of The Ministry of Health of the Russian Federation.
Abstract (Originalsprache)
Despite the widespread accessibility of vaccines and antivirals, seasonal influenza virus epidemics continue to pose a threat to public health. In this study, we constructed a recombinant replication-deficient simian adenovirus type 25 vector carrying the full-length hemagglutinin (HA) of the H1N1 influenza virus, named rSAd25-H1. Both systemic and mucosal humoral immune responses, as well as the protective efficacy, were assessed in mice immunized via the intramuscular (IM) or intranasal (IN) route. A single-dose IM or IN administration of rSAd25-H1 elicited a robust systemic IgG antibody response, including hemagglutination inhibition antibodies. As expected, only IN immunization was able to induce IgA production in serum and respiratory mucosa. Notably, a single dose of rSAd25-H1 at the highest dose (1010 viral particles) conferred complete protection against lethal homologous H1N1 challenge in mice despite the route of administration. These findings demonstrate the potential of simian adenovirus type 25-based vectors as a promising candidate for intranasal vaccine development targeting respiratory pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- N. F. Gamaleya Federal Research Center for Epidemiology & Microbiology, Ministry of Health, Moscow 123098, Russia.
ORCID-Profile: Daria V Voronina, Tatiana A Ozharovskaia, Olga Popova, Polina P Goldovskaya, Daria M Savina, Irina A Favorskaya, Dmitry V Shcheblyakov
Förderung
- State Assignment of The Ministry of Health of the Russian Federation
Zitieren
APA
Voronina, D. V., Vavilova, I. V., Zubkova, O. V., Ozharovskaia, T. A., Popova, O., Chugunova, A. S., Goldovskaya, P. P., Zrelkin, D. I., Savina, D. M., Favorskaya, I. A., Shcheblyakov, D. V., Logunov, D. Y., & Gintsburg, A. L. (2025). Single-Dose Intranasal or Intramuscular Administration of Simian Adenovirus-Based H1N1 Vaccine Induces a Robust Humoral Response and Complete Protection in Mice. Viruses. https://doi.org/10.3390/v17081085
Vancouver
Voronina DV, Vavilova IV, Zubkova OV, Ozharovskaia TA, Popova O, Chugunova AS, et al. Single-Dose Intranasal or Intramuscular Administration of Simian Adenovirus-Based H1N1 Vaccine Induces a Robust Humoral Response and Complete Protection in Mice. Viruses. 2025. doi:10.3390/v17081085
BibTeX
@article{Voronina2025,
author = {Voronina, Daria V and Vavilova, Irina V and Zubkova, Olga V and Ozharovskaia, Tatiana A and Popova, Olga and Chugunova, Anastasia S and Goldovskaya, Polina P and Zrelkin, Denis I and Savina, Daria M and Favorskaya, Irina A and Shcheblyakov, Dmitry V and Logunov, Denis Y and Gintsburg, Alexandr L},
title = {Single-Dose Intranasal or Intramuscular Administration of Simian Adenovirus-Based H1N1 Vaccine Induces a Robust Humoral Response and Complete Protection in Mice},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17081085}
}
EUVIMED